Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver
Wladimir Faber, Siamak Sharafi, Martin Stockmann, et al.
Surgery (2012) Vol. 153, Iss. 4, pp. 510-517
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
Kerstin Schütte, Christian Schulz, Janine Poranzke, et al.
BMC Gastroenterology (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 125
A double blinded prospective randomized trial comparing the effect of anatomic versus non-anatomic resection on hepatocellular carcinoma recurrence
Xiaobin Feng, Yongjie Su, Shuguo Zheng, et al.
HPB (2017) Vol. 19, Iss. 8, pp. 667-674
Open Access | Times Cited: 67
Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis
Xinsen Xu
World Journal of Gastroenterology (2014) Vol. 20, Iss. 31, pp. 10944-10944
Open Access | Times Cited: 62
Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols
Danijel Galun
World Journal of Hepatology (2015) Vol. 7, Iss. 20, pp. 2274-2274
Open Access | Times Cited: 52
Outcomes of hepatectomy for noncirrhotic hepatocellular carcinoma: A systematic review
Yanming Zhou, Xiaoyi Lei, Lupeng Wu, et al.
Surgical Oncology (2014) Vol. 23, Iss. 4, pp. 236-242
Closed Access | Times Cited: 45
Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma
Qiang Wang, Qi Chen, Xia Zhang, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 36, pp. 5515-5529
Open Access | Times Cited: 41
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 01, pp. e67-e161
Open Access | Times Cited: 4
Advances of diagnostic and mechanistic studies of γ-glutamyl transpeptidase in hepatocellular carcinoma
Jufeng Xia, Peipei Song, Zhipeng Sun, et al.
Drug Discoveries & Therapeutics (2016) Vol. 10, Iss. 4, pp. 181-187
Open Access | Times Cited: 36
Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges
Juan Wang, Xiaoya Wang, Xintong Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 02, pp. e82-e158
Closed Access
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion
Michael Bitzer, Sabrina Groß, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2025) Vol. 63, Iss. 03, pp. e159-e260
Closed Access
Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma
Tao Li, Lun‐Xiu Qin, Xiao Gong, et al.
Surgery (2014) Vol. 156, Iss. 3, pp. 651-660
Closed Access | Times Cited: 34
Prognosis Evaluation in Patients with Hepatocellular Carcinoma after Hepatectomy: Comparison of BCLC, TNM and Hangzhou Criteria Staging Systems
Chang Liu, Li-gen Duan, Wusheng Lu, et al.
PLoS ONE (2014) Vol. 9, Iss. 8, pp. e103228-e103228
Open Access | Times Cited: 33
High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma
Peipei Song, Yoshinori Inagaki, Zhigang Wang, et al.
Medicine (2015) Vol. 94, Iss. 21, pp. e810-e810
Open Access | Times Cited: 31
Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis
Satoshi Kitai, Masatoshi Kudo, Naoshi Nishida, et al.
Liver Cancer (2016) Vol. 5, Iss. 3, pp. 175-189
Open Access | Times Cited: 30
Myostatin as a fibroblast‐activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma
Sachiyo Yoshio, Tomonari Shimagaki, Ryuki Hashida, et al.
Hepatology Research (2021) Vol. 51, Iss. 7, pp. 803-812
Closed Access | Times Cited: 23
Efficacy of sequential TACE on primary hepatocellular carcinoma with microvascular invasion after radical resection: a systematic review and meta-analysis
Anwei Mo, Biquan Lin, Denglin Chen
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
Sabrina Groß, Michael Bitzer, Jörg Albert, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 02, pp. e213-e282
Open Access | Times Cited: 3
Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
Xiong Lei, Yunfeng Li, Guodong Chen, et al.
Oncotarget (2015) Vol. 6, Iss. 38, pp. 40622-40641
Open Access | Times Cited: 26
Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent
Georg Lurje, Jan Bednarsch, Zoltán Czigány, et al.
Langenbeck s Archives of Surgery (2018) Vol. 403, Iss. 7, pp. 851-861
Closed Access | Times Cited: 26
Development and validation of a risk score to predict the overall survival following surgical resection of hepatocellular carcinoma in non-cirrhotic liver
B. Dasari, Sivesh K. Kamarajah, James Hodson, et al.
HPB (2019) Vol. 22, Iss. 3, pp. 383-390
Open Access | Times Cited: 23
Systematic review of outcomes and meta-analysis of risk factors for prognosis after liver resection for hepatocellular carcinoma without cirrhosis
Qingsong Xie, Zixiang Chen, Yijun Zhao, et al.
Asian Journal of Surgery (2020) Vol. 44, Iss. 1, pp. 36-45
Open Access | Times Cited: 19
Can gamma-glutamyl transferase levels contribute to a better prognosis for patients with hepatocellular carcinoma?
Zhigang Wang, Peipei Song, Jufeng Xia, et al.
Drug Discoveries & Therapeutics (2014) Vol. 8, Iss. 3, pp. 134-138
Open Access | Times Cited: 21
Radiofrequency Ablation Versus Reresection in Treating Recurrent Hepatocellular Carcinoma
Hao Cai, Wentao Kong, Tie Zhou, et al.
Medicine (2014) Vol. 93, Iss. 22, pp. e122-e122
Open Access | Times Cited: 21
Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma
Xin Wang, Zusen Wang, Liqun Wu
BMC Surgery (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top